Cure My Disease

Don't miss your cure!

Home News About
Log in / Sign up
← Back to home

Inflarx Gmbh

Clinical trials sponsored by Inflarx Gmbh, explained in plain language.

Terminated 2
Sort by
  • Drug trial aims to heal painful, Hard-to-Treat skin wounds

    Disease control Terminated

    This study tested whether the drug vilobelimab could help heal painful, open skin ulcers caused by a rare condition called pyoderma gangrenosum. About 54 adults with at least one qualifying ulcer received either the drug or a placebo. The main goal was to see if the drug could le…

    Phase: PHASE3 • Sponsor: InflaRx GmbH • Aim: Disease control

    Last updated Mar 30, 2026 14:28 UTC

  • New pill tested for Tough-to-Treat skin conditions

    Disease control Terminated

    This study tested a new oral pill called INF904 in adults with moderate to severe chronic spontaneous urticaria (hives) or hidradenitis suppurativa (a painful skin condition). The main goal was to check the drug's safety and how it moves through the body over a 28-day treatment p…

    Phase: PHASE2 • Sponsor: InflaRx GmbH • Aim: Disease control

    Last updated Mar 09, 2026 14:23 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Terms of use Contact us

This is a site from Cyber and Space